GILEAD SCIENCES, INC. Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax
GILEAD SCIENCES, INC. (GILD) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax of -$13.00 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax · last filed 2018-05-09
- GILEAD SCIENCES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2018-03-31 was -$13.00M.
- GILEAD SCIENCES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2017-12-31 was $6.00M, a 98.13% decline year-over-year.
- GILEAD SCIENCES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2017-09-30 was -$51.00M.
- GILEAD SCIENCES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2017-06-30 was -$102.00M.
- GILEAD SCIENCES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2017 was -$276.00M, a 2223.08% decline from fiscal 2016.
- GILEAD SCIENCES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2016 was $13.00M.
- GILEAD SCIENCES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2015 was -$194.00M, a 144.70% decline from fiscal 2014.
- GILEAD SCIENCES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2014 was $434.00M.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 6 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 9 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 12 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | -$13.00M 10-Q · filed 2018-05-09 | -$7.00M derived: sum of 2 quarters · filed 2018-05-09 | -$58.00M derived: sum of 3 quarters · filed 2018-05-09 | -$160.00M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$45.00M derived: sum of 2 quarters · filed 2018-02-27 | -$147.00M derived: sum of 3 quarters · filed 2018-02-27 | -$276.00M 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | -$51.00M 10-Q · filed 2017-11-07 | -$153.00M derived: sum of 2 quarters · filed 2017-11-07 | -$282.00M 10-Q · filed 2017-11-07 | $39.00M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-06-30 | -$102.00M 10-Q · filed 2017-08-07 | -$231.00M 10-Q · filed 2017-08-07 | $90.00M derived: sum of 3 quarters · filed 2018-05-09 | $55.00M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-03-31 | -$129.00M 10-Q · filed 2018-05-09 | $192.00M derived: sum of 2 quarters · filed 2018-05-09 | $157.00M derived: sum of 3 quarters · filed 2018-05-09 | $114.00M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | $321.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $286.00M derived: sum of 2 quarters · filed 2018-02-27 | $243.00M derived: sum of 3 quarters · filed 2018-02-27 | $13.00M 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | -$35.00M 10-Q · filed 2017-11-07 | -$78.00M derived: sum of 2 quarters · filed 2017-11-07 | -$308.00M 10-Q · filed 2017-11-07 | -$369.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | -$43.00M 10-Q · filed 2017-08-07 | -$273.00M 10-Q · filed 2017-08-07 | -$334.00M derived: sum of 3 quarters · filed 2018-02-27 | -$417.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | -$230.00M 10-Q · filed 2017-05-10 | -$291.00M derived: sum of 2 quarters · filed 2018-02-27 | -$374.00M derived: sum of 3 quarters · filed 2018-02-27 | -$666.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | -$61.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$144.00M derived: sum of 2 quarters · filed 2018-02-27 | -$436.00M derived: sum of 3 quarters · filed 2018-02-27 | -$194.00M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | -$83.00M 10-Q · filed 2016-11-07 | -$375.00M derived: sum of 2 quarters · filed 2016-11-07 | -$133.00M 10-Q · filed 2016-11-07 | $0.00 derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | -$292.00M 10-Q · filed 2016-08-05 | -$50.00M 10-Q · filed 2016-08-05 | $83.00M derived: sum of 3 quarters · filed 2017-02-27 | $309.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $242.00M 10-Q · filed 2016-05-06 | $375.00M derived: sum of 2 quarters · filed 2017-02-27 | $601.00M derived: sum of 3 quarters · filed 2017-02-27 | $653.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $133.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $359.00M derived: sum of 2 quarters · filed 2017-02-27 | $411.00M derived: sum of 3 quarters · filed 2017-02-27 | $434.00M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $226.00M 10-Q · filed 2015-11-04 | $226.34M 10-Q · filed 2014-11-05 | $278.00M derived: sum of 2 quarters · filed 2015-11-04 | $301.00M 10-Q · filed 2015-11-04 | $300.91M 10-Q · filed 2014-11-05 | $267.55M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $52.00M 10-Q · filed 2015-08-05 | $51.63M 10-Q · filed 2014-08-04 | $75.00M 10-Q · filed 2015-08-05 | $74.58M 10-Q · filed 2014-08-04 | $41.55M derived: sum of 3 quarters · filed 2016-02-24 | -$37.52M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $23.00M 10-Q · filed 2015-05-08 | $22.95M 10-Q · filed 2014-05-07 | -$10.45M derived: sum of 2 quarters · filed 2016-02-24 | -$89.52M derived: sum of 3 quarters · filed 2016-02-24 | -$89.61M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | -$33.45M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$112.52M derived: sum of 2 quarters · filed 2016-02-24 | -$112.61M derived: sum of 3 quarters · filed 2016-02-24 | -$39.00M 10-K · filed 2016-02-24 | -$38.80M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | -$79.07M 10-Q · filed 2014-11-05 | -$79.16M derived: sum of 2 quarters · filed 2014-11-05 | -$5.55M 10-Q · filed 2014-11-05 | -$83.13M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | -$88.00K 10-Q · filed 2014-08-04 | $73.52M 10-Q · filed 2014-08-04 | -$4.06M derived: sum of 3 quarters · filed 2015-02-25 | -$109.18M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $73.61M 10-Q · filed 2014-05-07 | -$3.97M derived: sum of 2 quarters · filed 2015-02-25 | -$109.09M derived: sum of 3 quarters · filed 2015-02-25 | -$15.75M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | -$77.58M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | -$182.70M derived: sum of 2 quarters · filed 2015-02-25 | -$89.36M derived: sum of 3 quarters · filed 2015-02-25 | -$149.00M 10-K · filed 2015-02-25 | -$149.14M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | -$105.12M 10-Q · filed 2013-10-31 | -$11.78M derived: sum of 2 quarters · filed 2013-10-31 | -$71.42M 10-Q · filed 2013-10-31 | $18.45M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $93.34M 10-Q · filed 2013-08-01 | $33.70M 10-Q · filed 2013-08-01 | $123.58M derived: sum of 3 quarters · filed 2014-02-25 | $272.72M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | -$59.64M 10-Q · filed 2013-05-08 | $30.23M derived: sum of 2 quarters · filed 2014-02-25 | $179.37M derived: sum of 3 quarters · filed 2014-02-25 | $152.35M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $89.88M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $239.01M derived: sum of 2 quarters · filed 2014-02-25 | $212.00M derived: sum of 3 quarters · filed 2014-02-25 | $75.83M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $149.14M 10-Q · filed 2012-11-06 | $122.12M derived: sum of 2 quarters · filed 2012-11-06 | -$14.05M 10-Q · filed 2012-11-06 | |||||
| 2011-06-30 | -$27.02M 10-Q · filed 2012-08-01 | -$163.18M 10-Q · filed 2012-08-01 | ||||||
| 2010-12-31 | $38.06M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |